A randomised, double-blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial. (2019)
Attributed to:
HCN ion channels and pain
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/j.pain.0000000000001638
PubMed Identifier: 31188268
Publication URI: http://europepmc.org/abstract/MED/31188268
Type: Journal Article/Review
Volume: 160
Parent Publication: Pain
Issue: 11
ISSN: 0304-3959